# A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis

> **NCT00890552** · NA · COMPLETED · sponsor: **Stanford University** · enrollment: 25 (actual)

## Conditions studied

- Leukemia
- Amyloidosis

## Interventions

- **DRUG:** Lenalidomide
- **DRUG:** Melphalan
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT00890552
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2012-08
- **Final completion:** 2012-10
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2017-03-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00890552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00890552, "A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00890552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*